30results about How to "Efficient and cost-effective process" patented technology

A process and electrolytic cell for reducing in an ionic alkali metal compound, the cell containing anode and cathode electrodes, by supplying an electrolyte containing the alkali metal compound to the cell, applying an electric voltage to the cell to reduce said alkali metal compound at the cathode, and passing hydrogen or a hydrogen containing gas to at least one electrode while the compound is reduced at the cathode.

A system and method are disclosed which assist an employer in determining qualified candidates for positions of employment with the employer in an efficient and cost-effective manner. A preferred embodiment provides a software product that enables employers to generate a customized application program executable to interact with candidates and determine the qualified candidates for a position with the employer. More specifically, the software product receives as input from the employer a desired hiring criteria, and then generates a customized application program that utilizes the desired hiring criteria to determine the qualified candidates for the employer. Most preferably, a customized application program is generated, with which candidates may interact to effectively self-administer a qualification session for a position with the employer. In a most preferred embodiment, the generated application program may, upon determining a qualified candidate, take actions necessary to assist in further consideration of the qualified candidate. As an example, the application program may access a hiring manager's calendar, and schedule an interview for the qualified candidate at an available time. As a further example, the application program may forward information about the qualified candidate (e.g., resume, responses of the candidate to a questionnaire conducted by the application program, writing sample, letters of recommendation, etcetera) to the hiring manager via e-mail, fax, or some other method of communicating data.

The present invention details a sleeve and bushing of an electromechanical automatic planetary transmission. The sleeve and bushing operate to confine the desired flow of transmission lubricant through the components of the planetary gear arrangement. Additionally, the sleeve and bushing assist in maintaining a sufficient pressure level in the cavity of the planetary carrier to enable the lubricant to reach the bearings of the pinion gear. Moreover, the radius or size of the bushing / sleeve arrangement can be adjusted to occupy the radial clearance or cavity between the sun gear and main shaft for an automatic transmission with axially separable splined sun gear and sun gear shaft.

Keratinous fiber treatment formulations and methods of providing a long lasting set in keratinous fibers such as hair by applying a polymer system to the hair which provides a stable set to the hair which will last at least until the hair is thoroughly washed. The set is made more permanent by incorporating a reducing agent such as L-cysteine into the polymer system and allowing the system to air oxidize over time or optionally applying a second chemical oxidizing system to the treated hair which will accelerate the oxidation process and the setting rate of the hair.

The invention relates to a process for making of 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo-[3,4-b] pyrazin-5-yl-4-methyl piperazine-1-carboxylate, also known as zopiclone. The invention further describes an effective method for resolving of zopiclone into its enantiomers (eszopiclone and (R)-zopiclone) and also provides a method of recycling of (R)-zopiclone.

A method for preventing the formation of a bivalirudin precipitate during preparation of a pharmaceutical drug product comprising about 250 mg of bivalirudin, a dried bivalirudin drug product, and a concentrated liquid bivalirudin drug product. The method for preventing the formation of a bivalirudin precipitate comprises (i) preparing an aqueous solution comprising a buffer and a pH greater than the isoelectric point of bivalirudin; (ii) adding bivalirudin salt to the aqueous solution to form a bulk solution; (iii) transferring the bulk solution to one or more vessels; and (iv) drying the bulk solution. The buffer may have a pKa of about 4 to less than 7, and a pH greater than the isoelectric point of bivalirudin. The pH of the bulk solution may be maintained at a level greater than the isoelectric point of bivalirudin. Further, the bulk solution may have a final pH of about 4 to about 7.

The present disclosure relates to a simple one-pot process for the production of ammonia. The process involves electrolysis of air and water using a molten or concentrated aqueous hydroxide electrolyte in the presence of an iron catalyst. The process exhibits one or more of the following benefits: (i) it is an efficient, cost-effective low-energy process, (ii) it eliminates carbon dioxide (C02) evolution, (iii) it eliminates the need for a separator, and (iv) it bypasses the need for a preliminary hydrogenation step.

An improved system for removing bitumen from tar sands comprises a pre-treatment system utilizing a vibratory load hopper for classifying and sizing said tar sand particles communicating with a dryer for heating and drying said tar sand particles to a predetermined temperature thereby controlling the moisture content of said tar sands. An extraction system is also included for accepting said tar sands from the dryer comprising a plurality of extraction vessels arranged in series for transporting said tar sands from a first extraction vessel to a final extraction vessel. Furthermore, a solvent system for supplying a predetermined volume of solvent flow through said extraction vessels is employed, whereby solvent is supplied to the last extraction vessel and a solvent and bitumen mixture is withdrawn from the first extraction vessel.

The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

The invention provides a novel method for producing an antitoxic nonwoven fabric by molecularly grafting the antitoxic molecule thereto. The method comprises immersing a fibrous media comprising a material having a melt flow index of less than 150 MFI in a stable antitoxin solution comprising an antitoxin, preferably triiodide. The wet media is processed through rollers, thereby forcing the antitoxic molecule (e.g., iodine) to penetrate the media. The wet media is dried, and the fabric isolated therefrom. The invention further provides products incorporating the antitoxic media formed by this molecularly grafting method, including a wound dressing, surgical drape, privacy curtain, facemask, gown, article of protective clothing, shoe covering, hair covering, air filter, medical tape, and wipe.

The present invention is a building control system and method that comprises a first and second database where the first database is located remotely from the building control system and is synchronized with the second database which is located within the control system. The second database is used by the building control system to store configuration data and building system state data. The first database may be used to store preconfigured characteristics of a building control system before installation of the building control system. The present invention may also comprise a license database that provides license codes to the building control system where the building control system defaults to a minimum performance configuration if the building control system does not receive a valid code from the license database.

A temperature controlling protective device is made of a PPTC material, comprising: a body having two ends, a top surface and a bottom surface, and two ends of the body. Two electrodes made of silver gel respectively cover the two ends of the body. Two protective layers respectively cover the top surface and the bottom surface. The protective device may prevent electronic circuits from damage due to over heating.

The present invention relates to articles such as plastic closures molded from polymeric materials the like having a hydro-graphic film applied thereto for enhancing aesthetic appeal. The present invention further relates to techniques for applying a coating to articles, such as plastic closures, with a hydro-graphic film ink, which method contemplates application of the ink to the articles in a water bath without first drying the ink, thereby maintaining the ink in fluid state, desirably avoiding the time-consuming and sometimes problematic steps of drying and reactivating the hydro-graphic film ink.

The invention discloses a process for preparation of sertraline salts particularly sertraline hydrochloride Form V by dissolving or suspending sertraline mandelate in a solvent, reducing the pH of the solution or the suspension and isolating salt of sertraline The invention also provides for a pharmaceutical composition comprising said sertraline salt as active ingredient

To make possible a very small and compact embodiment of a coupler plug, especially for use for a planar broadband lambda probe having an adjusting unit, a coupler plug is configured in accordance with the following features:a coupler plug, especially for a planar lambda probe, made up ofa housing, namely a base element and a cover element having a primary locking mechanism;electrical components, that can be inserted and fixed in the housing; andan adjusting element for a probe, especially a planar broadband lambda probe, which is mounted in the coupler plug or outside the coupler plug, via a further contact element, the cover element additionally having a secondary locking mechanism, that is provided as a fixing element for fixing at least one electrical contact that is inserted in the housing, and this fixing element also has support elements that point to the cover element, the support elements being connected to the interior side of the cover element.

A dietary supplement for improving gastrointestinal functionality includes: an edible supplement comprising at least 10 mg / mL of alcohol soluble components of an animal broth. A method for preparing a dietary supplement for improving gastrointestinal functionality includes the steps of: transforming an animal broth into an active agent by adding a transforming vehicle to the animal broth, wherein the transforming vehicle is an alcohol; isolating the active agent by removing precipitates; removing the transforming vehicle from the active agent; and forming the dietary supplement, wherein the dietary supplement includes the active agent.

The invention relates to a process for separation of a processed vegetable fat (PVF), wherein said process comprises the steps of:in a distillation step (DIS), distilling the processed vegetable fat (PVF) into a distillate part (DPT) comprising stearic and oleic acid and / or esters thereof, and a distilled vegetable fat (DVF);in a first fractionation step (DFR), fractionating the distilled vegetable fat (DVF) into a first higher melting point fraction (FHF) being rich in tri-stearate triglycerides (StStSt, where St=stearic acid) and di-stearate diglycerides (StSt) and a first lower melting point fraction (FLF); andin a second fractionation step, fractionating the first lower melting point fraction (FLF) into a second higher melting point fraction (SHF) being rich in 1,3-distearyl-2-oleyl-triglycerides (StOSt, where O=oleic acid), and a second lower melting point fraction (SLF) being rich in 1-stearyl-2,3-dioleyl-triglycerides (StOO) and trioleate-triglycerides (OOO) in a solvent fractionation process (SFR).The invention furthermore relates to a vegetable fat product obtained from such process.

The present invention relates to preparation of key drug intermediate, L-2-amino butyric acid (L-2-ABA) by a method of cell free system and biotransformation using genetically engineered strains from easily available economic substrates like citramalate or citraconate and enzymes like LeuCD, LeuB and ValDH or IlvE.

The present invention is concerned with novel processes for the preparation of (R)-4,4-dimethoxy-pyran-3-ol. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity including CCR2 antagonists.